Quantcast

Latest Healthcare in India Stories

2011-05-07 00:00:28

Specialty biotech distributor announces twenty-five percent (25%) monthly growth rate of animal health division within rapidly expanding marketplace. Columbia, SC (PRWEB) May 06, 2011 BDI Pharma, Inc., the nation's fastest growing distributor of biotech therapies, announced continued growth in its expansion into the animal health market. 4legPharma, the Animal Health Division of BDI Pharma, was launched in October, 2010 to provide veterinarians and veterinary specialists a safe and...

2011-05-05 06:30:00

CALGARY, May 5 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2011 Annual General Meeting of the Shareholders will be held on Wednesday, May 11, 2011 at 4:30 p.m. ET at the Hilton Toronto Hotel, 145 Richmond Street West, Toronto, Ontario. Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN(®) as a potential cancer...

2011-05-04 06:00:00

SINGAPORE, May 4, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced the restructuring of its collaboration and option agreement with Onyx Pharmaceuticals, which was entered into in January 2009. As a result, S*BIO has regained North American and European rights to its novel JAK2 inhibitors, SB1518 and SB1578, from Onyx. Following a successful and productive partnership with Onyx, S*BIO will now be in a position to drive the development of its lead JAK2 program independently. Recent data...

2011-04-29 15:30:00

NEW YORK, April 29, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease (the "Company"), today announced its results for the first quarter ended March 31, 2011. At March 31, 2011, the Company had cash, cash equivalents and investment securities of $23.1 million, as compared to $28.5 million at...

2011-04-07 06:05:00

POINT RICHMOND, Calif., April 7, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Transcept management is scheduled to present at the Future Leaders in the Biotech Industry Conference on April 15, 2011 at 10:00 a.m. ET. A live audio webcast and replay of this presentation...

2011-04-05 07:30:00

ALISO VIEJO, Calif., April 5, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Future Leaders in the Biotech Industry Conference in New York City. Location: Millennium Broadway Hotel & Conference Center, New York, NY Presentation date: Friday April 15, 2011 Presentation time: 2:00pm ET A live webcast and 30-day archive of this presentation will be available at...

2011-03-31 06:30:00

CALGARY, March 31 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 10(th) Annual Needham Healthcare Conference on Tuesday, April 5(th), 2011 at 10:00 a.m. ET. The conference will take place on April 5(th) and 6(th) at the New York Palace Hotel in New York, NY. A live audio link to the webcast presentation is available at:http://www.wsw.com/webcast/needham44/oncy/,...

2011-03-16 14:11:10

In this week's PLoS Medicine, K. Srinath Reddy from the Public Health Foundation of India discusses new research published last week by Malavika Subramanyam, S V Subramanian, and colleagues that found no link between economic growth and child undernutrition rates in India, concluding that direct investments in appropriate health interventions may be necessary to improve child health in India. Dr. Reddy (not involved in the research study) emphasizes that poor health is not only the result of...

2011-03-07 07:00:00

LOS ANGELES, March 7, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has named Marvin S. Hausman M.D. as Chief Science Officer. Dr. Hausman has 30 years of drug development and clinical care experience at various pharmaceutical companies. "We are very fortunate to have Marvin Hausman join the team at Genesis Biopharma," said Anthony J. Cataldo, President and Chief Executive Officer....

2011-03-03 06:30:00

CALGARY, March 3 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 31(st) Annual Cowen and Company Healthcare Conference on Tuesday, March 8(th), 2011 at 8:45 a.m. ET. The conference will take place from March 7(th) to 9(th) at the Marriott Copley Place in Boston, MA. A live audio link to the webcast presentation is available at:...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.